Zonisamide improves axial symptoms in dementia with Lewy bodies with parkinsonism: Post hoc analysis of clinical trials

Patients with dementia with Lewy bodies (DLB) experience worsening axial symptoms with disease progression, which can negatively affect quality of life. Previous phase 2 and 3 clinical trials conducted in Japan showed that zonisamide improved parkinsonism in patients with DLB. In the present study,...

Full description

Bibliographic Details
Main Authors: Yoshio Tsuboi, Kenji Kochi, Hidenori Maruyama, Yuji Matsumoto
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:eNeurologicalSci
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405650221000770

Similar Items